By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Helix Biopharma Corp. 

3-305 Industrial Parkway

Aurora  Ontario  L4G 6X7  Canada
Phone: 905-841-2300-Ext-232 Fax: 905-841-2244




Company News
Helix Biopharma (TSX:HBP) Announces Upcoming Presentation Of L-DOS47 At World Conference On Lung Cancer 8/26/2015 11:32:05 AM
Helix Biopharma (TSX:HBP) Initiates Enrollment For Thirteenth Cohort In Polish Phase I/II Clinical Study Of Its Lung Cancer Drug Candidate L-DOS47 6/23/2015 11:44:59 AM
Helix Biopharma (TSX:HBP) Announces Q3 Fiscal 2015 Results 6/16/2015 12:59:40 PM
Helix Biopharma (TSX:HBP) Announces A Presentation At The Joint Conference Of The Canadian Society For Pharmaceutical Science And The Canadian Chapter Of The Controlled Release Society 5/28/2015 12:19:40 PM
Helix Biopharma (TSX:HBP) Retains The Trout Group As Investor Relations Advisor 5/20/2015 1:38:08 PM
Helix Biopharma (TSX:HBP) Closes Additional Private Placement Financing 4/30/2015 11:08:39 AM
Helix Biopharma (TSX:HBP) Provides An Update On The U.S. Study Of L-DOS47 4/23/2015 11:39:38 AM
Helix Biopharma (TSX:HBP) Announces Closing The First Tranche Of Subscriptions From Previously Announced Private Placement For Net CAD$5.2 Million And Receipt Of Net CAD$3.9 Million In Additional Subscription Agreements For A Total Net CAD$9.1 Million Private Placement Financing 4/3/2015 10:02:33 AM
Helix Biopharma (TSX:HBP) Announces The Receipt Of Subscription Agreements For A Net CAD5.2 Million Private Placement 3/16/2015 11:24:39 AM
Helix Biopharma (TSX:HBP) Announces Q2 Fiscal 2015 Results 3/10/2015 10:10:32 AM